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Abstract. The platform-independent software package consisting of the oligonucle-
otide mass assembler (OMA) and the oligonucleotide peak analyzer (OPA) was
created to support the analysis of oligonucleotide mass spectra. It calculates all
theoretically possible fragments of a given input sequence and annotates it to an
experimental spectrum, thus, saving a large amount of manual processing time. The
software performs analysis of precursor and product ion spectra of oligonucleotides
and their analogues comprising user-defined modifications of the backbone, the
nucleobases, or the sugar moiety, as well as adducts with metal ions or drugs. The
ability to expand the library of building blocks and to implement individual structural
variations makes it extremely useful for supporting the analysis of therapeutically
active compounds. The functionality of the software tool is demonstrated on the examples of a platinated double-
stranded oligonucleotide and a modified RNA sequence. Experiments also reveal the unique dissociation
behavior of platinated higher-order DNA structures.
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Introduction
The implementation of structural alterations to nucleic acidsis of major interest in the field of antisense RNA (asRNA)
research as well as RNA interference (RNAi) strategies.
Modifications are tailored to substantially enhance the cellular
stability of oligonucleotide-based therapeutic agents. Tandem
mass spectrometry (MS/MS) has been shown to be a versatile
tool for oligonucleotide sequencing, irrespective of limited
sample volume or modifications. The general fragmentation
pathways of oligonucleotides have been investigated exten-
sively in the past decades and it was shown that the product-
ions formed upon collision induced dissociation (CID) of DNA
and RNA are well predictable on the basis of the underlying
dissociation mechanisms [1–5]. Upon fragmentation, DNA
primarily forms a-B- and w-ions, whereas RNA preferentially
generates c- and y-ions (nomenclature byMcLuckey et al. [6]).
It has to be taken into account that the types of fragment ions
formed strongly depend on structural modifications present.
Oligonucleotides have gained attention as a target for
anticancer drugs. Formation of covalent bonds with oligonu-
cleotides was observed for transition metal complexes, such as
cisplatin. Cisplatin is one of the most widely used chemother-
apeutic drugs and was found to form adducts with DNA, RNA,
and proteins in vivo. The impact of cisplatin on the gas-phase
dissociation of single-stranded DNA and RNA has been
investigated extensively in the past few years [7, 8].
In vivo nucleic acids mainly occur in their double-stranded
form. Duplexes can be transferred into the gas phase by soft
ionization techniques, such as electrospray ionization (ESI) and
matrix-assisted laser desorption/ionization (MALDI) without
dissociation of the double strands occurring [9–12]. Soon after
successful ionization of duplex DNA, first tandem mass
spectrometric (MS/MS) studies were published [13, 14]. Dyson
and co-workers observed strand separation upon ESI-MS of
platinated DNA duplexes and subsequently subjected the
dissociated single strands to collision-induced dissociation
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(CID) to identify the adduct sites [15, 16]. These studies
demonstrated the potential of tandem mass spectrometry for
investigating the binding of therapeutically active compounds
to their target, but also pointed out the high complexity of the
product ion spectra, which renders data interpretation very
time-consuming. High-resolution tandemmass spectrometry is
a valuable tool to ensure structure confirmation and evaluation
of oligonucleotides for therapeutic purposes. However, pro-
cessing of large data sets without software support is
challenging and extremely laborious.
Software to support the interpretation of oligonucleotide
mass spectra has been reported earlier. Most of the available
tools focus on the a-B- and w-ions, which are known to be
most prevalently formed upon CID of DNA. Ni et al.
presented an algorithm that recognizes the peaks of 5'- and
3'-terminal fragments in the product ion spectra and builds a
mass ladder starting from the a2-B- and w1-ions [17]. The
authors stated that correlation of mass spectra might only
work up to the 15-mer level.
The web-tool MONGO [18] is able to calculate the m/z
values of the classic DNA fragments, as well as the M-, M-
B-, y-, d-H2O-ions, and internal fragments for a given
oligonucleotide sequence.
Oberacher et al. developed a comparative sequencing
(COMPAS) algorithm that compares in silico and experimental
m/z values of DNA fragments [19]. It calculates a fitting
value, which expresses the closeness of matching between
the measured and theoretical data. Sequence mutations are
detected readily by the COMPAS algorithm and it also
works for longer oligonucleotides (9 50 nucleobases).
Rozenski and McCloskey presented the simple oligonucle-
otide sequencer (SOS), which, for the first time, allowed
considering selected backbone and nucleoside modifications
[20].
With MS2links, a comprehensive tool for processing
biological macromolecules was developed as an integrated
part of the MS3D software suite [21, 22].
The software tool presented by Kretschmer et al. is
specialized in sequence confirmation of modified oligonucleo-
tides and also considers next neighbor position switches [23]. It
allows the implementation of user-defined modifications and
provides the opportunity to customize the output to obtain only
data on specific fragment-ions, such as c- and y-ions. Hence,
analysis of RNA product ion spectra is feasible as well. The
maximum number of nucleobases is limited, though, and it can
handle deconvoluted product ion spectra only.
Generally, the above mentioned software tools do not
support the interpretation of spectra of adducts formed
between (modified) oligonucleotides and metal ions or
drugs, nor do they perform simultaneous processing of two
hybridized strands.
Hence, an easy to use Java application was developed to
facilitate the interpretation of product ion spectra of native and
modified nucleic acids and their adducts. The oligonucleotide
mass assembler (OMA) and oligonucleotide peak analyzer
(OPA) combine many of the features of previous software and
provide additional functions that simplify the interpretation of
product ion spectra of oligonucleotides and of higher-order
nucleic acids in their native and modified forms. The software
is available for download from http://www.schuerch.dcb.unibe.
ch/omaopa/.
Experimental
Oligonucleotides, Chemicals, and Solvents
The single-stranded complementary DNA 15-mers (ss-1: 5'
ATTAGGTTGGTTATA 3'; ss-2: 5' TATAACCAACCTAAT
3') were custom-synthesized as triethylammonium salts on a
1.0 μmol scale by TriLink Biotechnologies (San Diego, CA,
USA) and used without further purification. Oligonucleotide
stock solutions were prepared by rediluting the lyophilized
sample with HPLC-grade water (Sigma-Aldrich Inc., Buchs,
Switzerland) to a concentration of 1 nmol/μL.
Annealing and Platination
Prior to annealing, the complementary single-strands were
diluted with a 300 mM NH4OAc (Sigma-Aldrich Inc., St.
Louis, MO, USA) buffer to yield a concentration of
500 pmol/μL. The oligonucleotide solutions were heated to
90 °C and cooled slowly over night to a final temperature of
20 °C. The formed duplexes were stored at −20 °C. The
single- and double-strands were incubated in a cisplatin
(Sigma-Aldrich Inc., St. Louis, MO, USA) solution in a
molar ratio of 1:1 (ss:cisplatin; ds:cisplatin) for 24 h at
37 °C. The platinated oligonucleotides were stored at
−20 °C. Prior to mass spectrometry, the unplatinated and
platinated duplexes were diluted with water to give a
final concentration of 100 pmol/μL. All samples were
analyzed immediately to reduce the time the duplex is
exposed to low buffer concentration, which could result
in dissociation of the double-strand.
Mass Spectrometry
All experiments were performed on a LTQ Orbitrap XL mass
spectrometer (Thermo Fisher Scientific, Bremen, Germany)
equipped with a nanoESI source. Oligonucleotides were
analyzed in negative ion mode with a potential of −850 V
applied to the nanospray needle and a source temperature of
130 °C. Tandem mass spectrometric experiments were
performed with the precursor-ions selected within a window
of ±3m/z. CID was performed with helium as the collision gas.
Spectra were acquired over a m/z range from 200 to
2000 and relative collision energies in the range from
20 % to 40 % were applied. Calibration of the
instrument was performed with ProteoMass LTQ/FT
Hybrid ESI Negative Mode Calibration Mix solution
(Supelco Analytical, Bellefonte, PA, USA). The Xcalibur
software package (Xcalibur 2.0.7, Thermo Fisher Scien-
tific) was used for data processing.
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Software Development
OMA and OPA were written in Java and, thus, run on all
platforms supporting the Java Runtime Environment 6 or later
(Windows, Mac OS X, Linux). The software consists of two
main parts. The first tool creates a reference peak list for a given
input sequence, OMA. A single or a double strand can be
entered, consisting of native or modified nucleotides. User-
defined modifications can be added easily. OMA calculates the
m/z values of all possible double- and single-strand molecular-
ions as well as all the corresponding a/a-B/b/c/d, w/x/y/z, and
internal fragments. The user can also choose to generate
sodium, potassium, and cisplatin adducts. The second software
part compares one or more generated reference lists to
experimental spectra, OPA. It allows to select the ions of
interest and also to specify a tolerance (in ppm) to account for
the individual mass accuracy of different mass spectrometers.
All spectra can be loaded from file or directly from the
clipboard and are rapidly annotated with matching peaks. The
format of the output is tab-separated, can be further processed
by any spreadsheet program (such as Microsoft Excel or
OpenOffice Calc).
Results and Discussion
Software-Supported Spectrum Interpretation:
Data Handling and Features
The capabilities of the OMA and OPA software are
demonstrated on MS and MS/MS data of the platinated 15-
mer DNA duplex 5'-ATTAGGTTGGTTATA-3'_3'-
TAATCCAACCAATAT-5'. All data were acquired on a
LTQ Orbitrap XL, processed with Xcalibur 2.0.7, extracted
with the built-in “export” option, and subsequently analyzed
with the new Java-based software tools. A significant benefit
of Java applications is their platform independence, as they
work on all major operating systems. All related programs
available so far were mainly programmed for Windows or
for specific application software such as Excel. Since only
tab-separated values are required for the OPA, any instru-
ment software that exports data in this manner can be used
with the new software tool. If the instrument software does
not generate tab-separated files, they can be easily created in
any spreadsheet program.
The software facilitates standardized analysis of oligonu-
cleotide product ion spectra by providing the opportunity to
search for specific fragment-ions and to consider peaks
within a certain error window only. The general procedure
of data evaluation is depicted in Figure 1.
Oligonucleotide Mass Assembler—OMA
The OMA allows to define one or two DNA/RNA or mixed
sequences and generates thereof a list of all theoretical
product ions, resulting from either backbone cleavage, base-
loss, formation of covalent and noncovalent adducts, or a
combination thereof (Figure 2). In contrast to other software
tools, the OMA also considers series of multiply charged
ions of single- and double-stranded sequences. Thus, not
only interpretation of product ion spectra is supported but
also processing of single-stage mass spectra. Peak lists
generated by the mass assembler are automatically written as
text files into the chosen directory.
Oligonucleotide Peak Analyzer—OPA
The peak analyzer imports the data as a text file in a tab-
separated manner from the given source and subsequently
compares the theoreticalm/z values with the experimental data.
The file needs to contain the column “m/z” for successful
matching. Optional data columns for the charge state or
absolute and relative peak intensities can be processed as well.
If the instrumental software exports the peak lists with the
annotated columns “m/z” and “Charge” right away, the m/z
values can be loaded directly from clipboard and do not have to
be saved as a text file in advance. The generated peak list is
either saved in a file or written back into the clipboard.
OPA settings are easily adjusted according to the needs of
the operator, as the data output can be customized by
selecting the types of fragment ions to be matched. Options
are provided for all product-ions generated by backbone
cleavage (a-B/a/w; b/x; c/y; d/z) as well as base loss from the
precursor ion (Figure 3). By default, the OPA is able to
consider the presence of internal fragments, sodium and
potassium adducts, as well as platination by cisplatin.
To account for instruments that generate low resolution
data, the software is able to calculate and match the average
masses of fragment-ions, if the corresponding box is
checked. The tolerance window for peak recognition can
be set individually. However, it has to be taken into account
that a wider window will result in a larger number of false
positive results, which renders manual re-evaluation of the
assignments necessary.
Figure 1. General workflow of the OMA and OPA software.
Oligonucleotide MS/MS data are acquired experimentally.
The m/z values of theoretically possible fragment ions are
calculated by the OMA and, finally, experimental and
simulated data are matched by the OPA, which exports the
result in a spreadsheet compatible form
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For unambiguous peak assignment, the charge states of the
ions are considered as well. Results are written into a spreadsheet
providing the specifics of the peaks in a tabulated manner. If
desired, only findings that match both, the m/z value and the
charge state, will be inserted into the final peak list and charge
mismatches will be excluded. Otherwise, the corresponding
fragments are marked by a question mark in the result. The final
output is given either as a full peak list, also including the peaks
that have not been annotated, or as a truncated list containing the
assigned peaks only. To support re-evaluation of the results, the
theoretical reference mass and the mass error between calculated
and experimental masses can be added to the output.
Example 1: Platinated Double-Stranded DNA
Successful transfer of a platinated duplex was achieved by
carefully optimizing the ionization conditions. The resulting
mass spectrum shows the peaks of the platinated and
unplatinated duplex as well as of the corresponding
unannealed single-strands ss1 and ss2 (inset in Figure 4).
Tandem mass spectrometry was performed with the intact
sevenfold negatively charged platinated duplex as the precursor
ion. Hence, fragments of both strands are present in the product
ion spectrum. For data processing, the sequences of the two
strands are entered into the OMA and the types of adduct ions
to be considered are selected. The software creates a file
containing the theoretical m/z values of the fragments of both
single strands, which serves as input for the OPA.
After matching of the data, the fragment ion output is
individualized with the corresponding prefix ss1 or ss2,
according to the respective strand. That the sequences are
entered into the OMA individually has the benefit that the
single strands do not have to be complementary. Hence,
spectra of oligonucleotides that inherently do not hybridize
perfectly are analyzed correctly by the software.
Table S1 gives an overview of the results obtained by
processing the MS/MS data of the platinated double-
stranded DNA with different settings. The comparison
illustrates that efficiency of the evaluation and clarity of
the output are increased by restricting the types of fragment
ions and limiting the number of peaks to be matched. The
results obtained by applying more stringent settings are
summarized in Supplemental Figure S1. Matching was
based on the 250 most abundant ions and the selection of
fragment ion types was limited to a-B- and w-ions, base
losses, and cisplatin adducts. Also included are the multiply
charged ions of the single- and double-strands.
The product ion spectra of the unplatinated and platinated
double-strands were found to differ considerably. Collisional
activation of the unplatinated duplex (m/z 1304.23, z0−7)
yielded almost exclusively the corresponding dissociated
single-strands (Figure 4a). Figure 4b shows the product ion
spectrum of the platinated duplex (m/z 1336.66, z0−7). It
reveals that cleavage of covalent bonds is considerably more
pronounced after addition of cisplatin, and the formation of
internal fragment ions is increased as well. Internal frag-
Figure 2. Screenshot of the OMA generating the peak list for a platinated duplex. For the platinated double-stranded DNA
15-mer more than 430,000 potential fragment ions are calculated if all options are selected
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ments of w-/a-B-character constitute the majority amongst
all dissociation products. The nomenclature of internal
fragments is explained in Supplemental Figure S2.
The potential cleavage sites from which an internal
fragment can result are also given in the spreadsheet
output. For the sequence AGTTACT, the internal fragment
Figure 3. OPA graphical user interface allowing customized output of peak annotations
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[w-{--TTddd}a-B-]-1 (Supplementary Figure S2) would addi-
tionally be assigned as [w5 09 a5-B] fragment. Since short
internal fragments can often originate from various positions
within a sequence, all of them are listed (e.g., [w5 09 a13-B],
[w9 09 a9-B], and [w14 09 a4-B] for ss1 (ATTAGGTTGGT
TATA)); ss1 was mainly detected in its platinated form,
whereas ss2 showed a highly abundant peak referring to the
unplatinated single-strand. This observation is in good agree-
ment with the expected preference of platination according to
the sequences. The fact that the platinated double-strand did not
yield any platinated fragment was unexpected, since despite the
two positive charges introduced by cisplatin, the number of
charges on the backbone should be sufficiently high for
compensation. However, smaller internal fragments compris-
ing two or three phosphate groups only can be precluded from
detection in the mass spectrometer due to platination.
In order to obtain more information on the precise
platination site, the triply negatively charged [ss1 + cisPt]-ion
(m/z 1619.61), which was generated upon dissociation of the
platinated double-strand, was subjected to a further dissociation
step in aMS3 experiment (Figure 5). Twomajor pathwayswere
observed. The first one is extensive neutral loss of purine bases,
Figure 4. Product ion spectra of (a) the unplatinated and (b) the platinated double-stranded DNA. The sevenfold negatively
charged ions were selected as the precursors for CID. The relative collision energy was set to 25 %. Inset: Electrospray mass
spectrum demonstrating successful gas-phase transfer of the platinated double-stranded DNA. ss1 and ss2 refer to the
unhybridized single-strands, whereas DS indicates the double-stranded DNA
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and the second one is the preferred cleavage of the 3'-C–O
bond adjacent to the vicinal nucleobases G9G10 (formation of
the w5-ion), indicating that cisplatin-binding predomi-
nantly occurred at this position [7]. However, the presence of an
a9-B + cisPt-ion gives evidence for G5G6 at the beginning of the
sequence representing an alternative binding site for cisplatin.
The example of double-stranded DNA, which generates a
large number of product-ions, shows that the software strongly
facilitates fast and reliable data interpretation. It further
demonstrates that assignment of cisplatin adduct sites within
DNA duplexes is feasible, if MS3 data can be acquired.
User-Defined Modifications
Besides the processing of product ion spectra of DNA and its
adducts, the OMA and OPA software package was programmed
to support the analysis of single- and double-stranded RNA and
modified nucleic acids as well. Various types of nucleobases,
sugar moieties, and backbone linkers are provided by the user
interface (Supplementary Figures S2 and S3), which appears by
clicking on the “insert” button of the initial OMA window
(Figure 2). Each modification is illustrated by a small icon.
In order to account for the steadily increasing number of
structural modifications introduced into therapeutic oligonu-
Figure 5. (a) MS3 spectrum of triply negatively charged
[ss1 + cisPt], which was generated by strand separation
of the platinated duplex in the first activation stage.
Internal fragments are represented by the symbols *: [w-
{−−TTddd}a-B], #: [w-{−−−TTGdddd}a-B], ‡: [w-{−−
−ATTdddd}a-B]. (b) Overview of the cleavage sites, with
the font size of the fragment labels indicating the relative
intensity. Pt(NH3)2 is abbreviated by cisPt
Figure 6. (a) Product ion spectrum and sequence of the platinated 2'-methoxy-methylphosphonate RNA. (b) OPA output for
the modified sequence
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cleotides, the library on which calculation of fragment ions
by the OMA is based is expandable. Expansion of the oma.lib
is straightforward, since solely the elemental composition and
the desired abbreviation of the modification have to be entered
in a new line (Supplementary Figure S4).
Example 2: Modified RNA
In Figure 6a, the product ion spectrum of a platinated 2'-
methoxy-methylphosphonate oligoribonucleotide, together
with its sequence and the most abundant product ions, are
shown. The strength of the OMA software is that it also
accepts oligonucleotides bearing multiple modifications at
different positions. In the example given, the sequence was
entered into the OMA interface as mC-mC-mG_mG_mU-
mU (with _ indicating the backbone modification). The
output obtained by considering all possible types of
fragment ions is shown in Figure 6b. In contrast to
unmodified RNA, abundant fragment ions were assigned
as members of the d- and z-ion series, which is in good
agreement with the dissociation mechanisms of methoxy-
methylphosphonate [8].
Conclusions
The OMA/OPA package represents a new generation of
software to support the interpretation of oligonucleotide
product ion spectra. Since it is based on Java, it is independent
of the operating system. It combines features of previous
programs and exhibits additional functions, such as free
expandability of the building block library with modifications,
direct analysis of the double-strand MS/MS data, and inclusion
of sodium, potassium, and cisplatin adducts. The functionality
of the software is demonstrated on the example of a platinated
double-stranded 15 bp DNA and a highly modified oligor-
ibonucleotide. It is demonstrated that processing of product ion
spectra of the unplatinated and the platinated duplex is
considerably simplified and that the time for thorough
interpretation of the analytical data of is reduced considerably.
Furthermore, results reveal the influence of platination on the
dissociation behavior of the platinated double-stranded DNA.
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